Chlorisondamine

Chlorisondamine.svg

Chlorisondamine is a ganglionic blocker that is used primarily in research settings. It is a quaternary ammonium compound and acts as a competitive antagonist at nicotinic acetylcholine receptors (nAChRs) in the autonomic ganglia.

Mechanism of Action

Chlorisondamine works by inhibiting the transmission of nerve impulses in the autonomic nervous system. It binds to the nicotinic acetylcholine receptors at the ganglia, preventing the action of acetylcholine, a neurotransmitter responsible for the activation of these receptors. This results in the blockade of both sympathetic and parasympathetic outflow.

Uses

While Chlorisondamine is not commonly used in clinical practice, it is valuable in pharmacological research to study the role of nicotinic receptors in various physiological and pathological processes. It has been used in studies investigating hypertension, cardiovascular diseases, and neurodegenerative disorders.

Pharmacokinetics

As a quaternary ammonium compound, Chlorisondamine is poorly absorbed from the gastrointestinal tract and does not easily cross the blood-brain barrier. This limits its effects primarily to the peripheral nervous system.

Side Effects

Due to its action on the autonomic ganglia, Chlorisondamine can cause a range of side effects, including hypotension, tachycardia, dry mouth, constipation, and urinary retention. These side effects are a result of the blockade of autonomic ganglionic transmission.

Related Compounds

Chlorisondamine is related to other ganglionic blockers such as hexamethonium and mecamylamine. These compounds share a similar mechanism of action but differ in their chemical structure and pharmacokinetic properties.

History

Chlorisondamine was first synthesized in the mid-20th century and has since been used primarily in experimental settings. Its role in clinical medicine has been limited due to the availability of more selective agents for the treatment of autonomic disorders.

See Also

• Ganglionic blocker
• Nicotinic acetylcholine receptor
• Autonomic nervous system
• Hypertension
• Neurodegenerative disorders

External Links

-

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian